Spyre Therapeutics, Inc. ( SYRE) - Key Metrics
SYRE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.43 | -$0.82 | -$0.82 |
| 2026Q1 | $0 | -$0.88 | -$0.73 | -$0.73 |
| 2025Q4 | $1.21 | -$0.83 | -$0.59 | -$0.59 |
| 2025Q3 | $0 | -$0.15 | -$0.50 | -$0.50 |
| 2025Q2 | $0 | -$0.60 | -$0.77 | -$0.77 |
SYRE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -61.65 |
| 2026Q1 | 0% | -17.04 |
| 2025Q4 | 0% | -11.70 |
| 2025Q3 | 0% | -27.93 |
| 2025Q2 | 0% | -6.24 |
SYRE
Price: $108.92
52 week price:
Earnings Per Share: -1.93 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 9.1 billion